会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Peptide inhibitors of neurotransmitter secretion by neuronal cells
    • 神经递质分泌神经元细胞的肽抑制剂
    • US06169074A
    • 2001-01-02
    • US08819286
    • 1997-03-18
    • Mauricio MontalJaume M. CanavesAntonio V. Ferrer-Monteil
    • Mauricio MontalJaume M. CanavesAntonio V. Ferrer-Monteil
    • C07K708
    • C07K14/33A61K38/00C07K2319/00Y02A50/469
    • The invention consists of peptides which inhibit the secretion of neurotransmitters from synaptic vesicles. The peptides of the invention are believed to mimic the activity of neurotoxins produced by Clostridium botulinum and tetani (including botulinum serotypes A, B, C, D, E, F and G). Structurally, the peptides are comprised of amino acid fragments from the substrate binding domains selected from three proteins which bind to form a receptor for docking of synaptic vesicles to the plasma membranes of neuronal cells; i.e., SNAP-25, VAMP-2 and syntaxin. Certain of the inventive peptides exhibit strong inhibitory activity; e.g., 50% or greater decline in neurotransmitter release is obtained at even nanomolar concentrations. The peptides are suited for use as substitutes for Clostridium neurotoxins in clinical applications and in compounds for targeted delivery of drugs into neural cells.
    • 本发明由抑制神经递质从突触小泡分泌的肽组成。 据信本发明的肽模拟肉毒杆菌和破伤风(包括肉毒杆菌血清型A,B,C,D,E,F和G)产生的神经毒素的活性。 结构上,肽由选自三种蛋白质的底物结合结构域的氨基酸片段组成,三种蛋白质结合形成突触小泡对接神经元细胞的质膜的受体; 即SNAP-25,VAMP-2和syntaxin。 某些本发明的肽表现出强的抑制活性; 例如在甚至纳摩尔浓度下获得神经递质释放的50%或更大的下降。 这些肽适合用作临床应用中的Clostridium神经毒素的替代物和用于将药物靶向递送至神经细胞的化合物。
    • 5. 发明授权
    • Chemically-modified clostridiatoxin with improved properties
    • 化学修饰的梭菌毒素具有改善的性质
    • US5837265A
    • 1998-11-17
    • US612571
    • 1996-03-08
    • Mauricio MontalAntonio Ferrer-Montiel
    • Mauricio MontalAntonio Ferrer-Montiel
    • A61K38/00A61K39/08C07K14/33A61K39/00A61K39/02A61K39/06
    • C07K14/33A61K39/08A61K38/00Y10S424/832
    • The invention consists of modified Clostridium neurotoxin compounds, pharmaceutical compositions containing such compounds and methods for preparing such compounds. In particular, the compounds of the invention are purified Clostridium botulinum and Clostridium tetani neurotoxins in which the tyrosine residues have been modified to have a negative charge (e.g., by covalent attachment of a phosphate or sulphate thereto) or in which the tyrosine residues have been substituted with amino acids having a negative charge (e.g., glutamate, aspartate, or negatively charged, non-natural amino acids). Toxins having phosphorylated tyrosine residues in both the light and heavy chains of the toxins are preferred. Methods for enzymatic and chemical modification of tyrosine residues in purified Clostridium neurotoxins are provided.
    • 本发明由改良的梭状芽胞杆菌神经毒素化合物,含有这些化合物的药物组合物和制备这些化合物的方法组成。 特别地,本发明的化合物是精制的肉毒梭菌和破伤风梭菌神经毒素,其中酪氨酸残基被修饰为具有负电荷(例如,通过共价连接磷酸盐或硫酸盐)或其中酪氨酸残基已被 由具有负电荷的氨基酸(例如谷氨酸,天冬氨酸或带负电荷的非天然氨基酸)取代。 在毒素的轻链和重链都具有磷酸化酪氨酸残基的毒素是优选的。 提供了纯化的梭菌属神经毒素中酪氨酸残基酶促和化学修饰的方法。